Home › Funds › Omega Fund Management, LLC › IMUX
Omega Fund Management, LLC position in IMUX
IMMUNIC INC · Health Care
Omega Fund Management, LLC reported holding 430,180 shares of IMUX (IMMUNIC INC) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 3.20% of its reported portfolio and ranking #6 among its reported holdings. Omega Fund Management, LLC has disclosed IMUX holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Omega Fund Management, LLC's IMUX position evolved
Omega Fund Management, LLC first disclosed a stake in IMUX in Q3 2023 at 1,788,160 shares (US$2.6M). The position peaked in Q3 2026 at 430,180 shares, worth US$4.0M. Across 9 filings, Omega Fund Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 430,180 shares valued at US$4.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.79M | $2.63M | New |
| Q4 2023 | 1.79M | $2.68M | Hold |
| Q1 2024 | 1.79M | $2.36M | Hold |
| Q2 2024 | 1.79M | $1.98M | Hold |
| Q3 2024 | 1.79M | $2.95M | Hold |
| Q4 2024 | 1.79M | $1.79M | Hold |
| Q1 2025 | 1.79M | $1.95M | Hold |
| Q2 2025 | 1.79M | $1.25M | Hold |
| Q3 2026 | 430.18K | $4.00M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMUX and 13F data
IMUX (IMMUNIC INC) is a Health Care company. 37 other funds we track also report a position in IMUX — the largest reported positions include BVF INC/IL (US$11.8M), Avidity Partners Management LP (US$10.3M), Propel Bio Management, LLC (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMUX
- BVF INC/IL 765.29K sh · $11.76M · Q2 2026
- Avidity Partners Management LP 669.94K sh · $10.30M · Q2 2026
- Propel Bio Management, LLC 236.73K sh · $2.20M · Q3 2026
More on Omega Fund Management, LLC
FAQ
How long has Omega Fund Management, LLC held IMUX?
Omega Fund Management, LLC has disclosed IMUX holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is Omega Fund Management, LLC's current position in IMUX?
As of Q3 2026, Omega Fund Management, LLC holds 430.18K shares of IMUX (IMMUNIC INC), valued at $4.00M, representing 3.20% of its reported portfolio and ranking #6.
Has Omega Fund Management, LLC been buying or selling IMUX?
In the latest 13F filing (Q3 2026), Omega Fund Management, LLC newly opened its position in IMUX. The position peaked in Q3 2026 at 430.18K shares.
Which other funds hold IMUX?
Other major institutional holders of IMUX include BVF INC/IL, Avidity Partners Management LP, Propel Bio Management, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.